Eric d'Esparbes
2015 - Innoviva
In 2015, Eric d'Esparbes earned a total compensation of $1.1M as Senior Vice President and Chief Financial Officer at Innoviva, a 49% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $182,585 |
|---|---|
| Salary | $383,840 |
| Stock Awards | $485,997 |
| Other | $8,958 |
| Total | $1,061,380 |
d'Esparbes received $486K in stock awards, accounting for 46% of the total pay in 2015.
d'Esparbes also received $182.6K in non-equity incentive plan, $383.8K in salary and $9K in other compensation.
Rankings
In 2015, Eric d'Esparbes' compensation ranked 7,656th out of 13,638 executives tracked by ExecPay. In other words, d'Esparbes earned more than 43.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,656 out of 13,638 | 44th |
Division Manufacturing | 2,901 out of 5,190 | 44th |
Major group Chemicals And Allied Products | 1,048 out of 1,854 | 44th |
Industry group Drugs | 845 out of 1,528 | 45th |
Industry Pharmaceutical Preparations | 665 out of 1,182 | 44th |
Source: SEC filing on March 25, 2016.
d'Esparbes' colleagues
We found four more compensation records of executives who worked with Eric d'Esparbes at Innoviva in 2015.
News
BIORA THERAPEUTICS CEO Adi Mohanty's 2023 pay slips 11% to $3.1M
April 24, 2024
BIORA THERAPEUTICS CEO Adi Mohanty's 2022 pay falls 65% to $3.5M
April 27, 2023
BIORA THERAPEUTICS CEO Adi Mohanty receives $10M in 2021
April 28, 2022
BIORA THERAPEUTICS CEO Harry Stylli's 2020 pay jumps 1,357% to $5.8M
April 15, 2021
Innoviva CEO Michael Aguiar's 2018 pay slips 11% to $3.7M
March 13, 2019